Merrimack Pharmaceuticals Market Cap

Merrimack Pharmaceuticals has a market cap or net worth of $213.76 million as of April 24, 2024. Its market cap has increased by 17.45% in one year.

Market Cap

213.76M

Enterprise Value

194.89M

1-Year Change

17.45%

Ranking

#3582

Market Cap Chart

Since March 29, 2012, Merrimack Pharmaceuticals's market cap has decreased from $572.30M to $213.76M, a decrease of -62.65%. That is a compound annual growth rate of -7.83%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	213.80M	-
Apr 22, 2024	213.80M	0.05%
Apr 19, 2024	213.70M	0.28%
Apr 18, 2024	213.10M	-
Apr 17, 2024	213.10M	-
Apr 16, 2024	213.10M	-
Apr 15, 2024	213.10M	-
Apr 12, 2024	213.10M	-0.33%
Apr 11, 2024	213.80M	0.05%
Apr 10, 2024	213.70M	-0.05%
Apr 9, 2024	213.80M	0.19%
Apr 8, 2024	213.40M	-0.05%
Apr 5, 2024	213.50M	0.05%
Apr 4, 2024	213.40M	-0.05%
Apr 3, 2024	213.50M	-0.14%
Apr 2, 2024	213.80M	-0.09%
Apr 1, 2024	214.00M	-0.19%
Mar 28, 2024	214.40M	0.14%
Mar 27, 2024	214.10M	0.19%
Mar 26, 2024	213.70M	-0.05%
Mar 25, 2024	213.80M	-0.42%
Mar 22, 2024	214.70M	0.70%
Mar 21, 2024	213.20M	-
Mar 20, 2024	213.20M	-
Mar 19, 2024	213.20M	-0.23%

View and export this data all the way back to 2012. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Accuray	220.15M
Foghorn Therapeutics	219.64M
G1 Therapeutics	218.72M
Generation Bio Co.	216.72M
Lineage Cell Therapeutics	214.93M
Stereotaxis	210.25M
Elevation Oncology	210.17M
Galectin Therapeutics	209.23M

Market Cap Rankings